- /
- Supported exchanges
- / US
- / SGIOF.PINK
Shionogi & Co. Ltd (SGIOF PINK) stock market data APIs
Shionogi & Co. Ltd Financial Data Overview
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Shionogi & Co. Ltd data using free add-ons & libraries
Get Shionogi & Co. Ltd Fundamental Data
Shionogi & Co. Ltd Fundamental data includes:
- Net Revenue: 637 089 M
- EBITDA: 177 185 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-30
- EPS/Forecast: 42.54
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shionogi & Co. Ltd News
New
Vocabria + Rekambys associated with greater adherence versus daily oral therapy in a US real-world study, as ViiV Healthcare presents broader long-acting portfolio and pipeline data at HIV Glasgow
Findings showcase the real-world effectiveness of long-acting injectable medicines across groups with unmet needs; new pipeline data highlight the potential for twice-yearly HIV treatment LONDON, Nov...
SGIOY vs. UTHR: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and United Therapeutics (UTHR). But which of these two compan...
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Q2 Earnings Lag Estimates
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.18 per share ...
D-Wave Customer Shionogi Wins First Place in NEDO Quantum Computing Challenge’s Quality of Life Category
¥40 million prize will support continued research exploring the application of quantum computing to drug discovery, with achievements including, among others, a peer-reviewed study using D-Wave's ann...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.